Infectious Disease Molecular Diagnostics Market Size Record US$ 50.8 Bn by 2030

SHARE THIS ARTICLE

The global Infectious Disease Molecular Diagnostics market size is expected to be worth around US$ 50.8 billion by 2030, according to a new report by Vision Research Reports.

The global Infectious Disease Molecular Diagnostics market size was valued at US$ 40.4 billion in 2020 and is anticipated to grow at a CAGR of 10.0% during forecast period 2021 to 2030.

Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38475

Infectious Disease Molecular Diagnostics Market Size 2021 to 2030

Key Players

  • Abbott
  • Danaher Corporation
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc. (Gen-Probe)
  • Illumina, Inc.
  • Grifols S.A.
  • Qiagen
  • Siemens Healthineers AG
  • Sysmex Corporation
Report Coverage Details
Market Size US$ 50.8 billion by 2030
Growth Rate CAGR of 10.0% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, End-use, Technology, Application
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Abbott; Becton, Dickinson and Company; bioMérieux SA; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Danaher Corporation; Hologic, Inc. (Gen-Probe); Illumina, Inc.; Grifols S.A.; Qiagen; F. Hoffmann-La Roche Ltd, Siemens Healthineers AG; Sysmex Corporation

Market Segmentation

  • Product
    • Instruments
    • Reagents
    • Services
  • End-use
    • Hospitals
    • Clinics
    • Diagnostics Laboratories
    • Research Institutes
  • Technology
    • Polymerase chain reaction (PCR)
      • PCR, by Type
        • Multiplex PCR
        • Other PCR
      • PCR, by Product
        • Instruments
        • Reagents
        • Services
    • In Situ Hybridization
      • Instruments
      • Reagents
      • Services
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • Instruments
      • Reagents
      • Services
    • Chips and Microarrays
      • Instruments
      • Reagents
      • Services
    • Mass Spectrometry
      • Instruments
      • Reagents
      • Services
    • Sequencing
      • Instruments
      • Reagents
      • Services
    • Transcription Mediated Amplification
      • Instruments
      • Reagents
      • Services
    • Others
      • Instruments
      • Reagents
      • Services
  • Application
    • Respiratory Diseases
    • Tuberculosis
    • Meningitis
    • Gastrointestinal Tract Infections
    • HPV
    • Sexually Transmitted Infections
    • Sepsis
    • Drug Resistance Diseases
    • Other Infectious Diseases

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw End-use Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Infectious Disease Molecular Diagnostics Market, By Product

7.1.  Infectious Disease Molecular Diagnostics Market, by Product, 2021-2030

7.1.1.    Instruments

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Reagents

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Services

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Infectious Disease Molecular Diagnostics Market, By End-use

8.1.  Infectious Disease Molecular Diagnostics Market, by End-use, 2021-2030

8.1.1.    Hospitals

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Clinics

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Diagnostics Laboratories

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Research Institutes

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Infectious Disease Molecular Diagnostics Market, By Technology

9.1.  Infectious Disease Molecular Diagnostics Market, by Technology, 2021-2030

9.1.1.    Polymerase chain reaction (PCR)

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    In Situ Hybridization

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Isothermal Nucleic Acid Amplification Technology (INAAT)

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Chips and Microarrays

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    Mass Spectrometry

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Sequencing

9.1.6.1.        Market Revenue and Forecast (2017-2030)

9.1.7.    Transcription Mediated Amplification

9.1.7.1.        Market Revenue and Forecast (2017-2030)

9.1.8.    Others

9.1.8.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Infectious Disease Molecular Diagnostics Market, By Application

10.1.        Infectious Disease Molecular Diagnostics Market, by Application, 2021-2030

10.1.1.  Respiratory Diseases

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Tuberculosis

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Meningitis

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Gastrointestinal Tract Infections

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  HPV

10.1.5.1.      Market Revenue and Forecast (2017-2030)

10.1.6.  Sexually Transmitted Infections

10.1.6.1.      Market Revenue and Forecast (2017-2030)

10.1.7.  Sepsis

10.1.7.1.      Market Revenue and Forecast (2017-2030)

10.1.8.  Drug Resistance Diseases

10.1.8.1.      Market Revenue and Forecast (2017-2030)

10.1.9.  Other Infectious Diseases

10.1.9.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Infectious Disease Molecular Diagnostics Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2017-2030)

11.1.2.  Market Revenue and Forecast, by End-use (2017-2030)

11.1.3.  Market Revenue and Forecast, by Technology (2017-2030)

11.1.4.  Market Revenue and Forecast, by Application (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by Application (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2017-2030)

11.2.2.  Market Revenue and Forecast, by End-use (2017-2030)

11.2.3.  Market Revenue and Forecast, by Technology (2017-2030)

11.2.4.  Market Revenue and Forecast, by Application (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by Application (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2017-2030)

11.3.2.  Market Revenue and Forecast, by End-use (2017-2030)

11.3.3.  Market Revenue and Forecast, by Technology (2017-2030)

11.3.4.  Market Revenue and Forecast, by Application (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by Application (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2017-2030)

11.4.2.  Market Revenue and Forecast, by End-use (2017-2030)

11.4.3.  Market Revenue and Forecast, by Technology (2017-2030)

11.4.4.  Market Revenue and Forecast, by Application (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by Application (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2017-2030)

11.5.2.  Market Revenue and Forecast, by End-use (2017-2030)

11.5.3.  Market Revenue and Forecast, by Technology (2017-2030)

11.5.4.  Market Revenue and Forecast, by Application (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by Application (2017-2030)

Chapter 12.  Company Profiles

12.1.              Abbott

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Danaher Corporation

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              bioMérieux SA

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              F. Hoffmann-La Roche Ltd

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Bio-Rad Laboratories, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Agilent Technologies, Inc.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Becton, Dickinson and Company

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Hologic, Inc. (Gen-Probe)

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Illumina, Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Grifols S.A.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Qiagen

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Siemens Healthineers AG

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Sysmex Corporation

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38475 or call: +1 9197 992 333

Daksh

Daksh is an SEO Analyst having 3 years of experienced. we can quickly understand and support initiatives that will contribute to the goals and success of client campaigns. and also Perform keyword research in coordination with client business objectives to optimize existing content and uncover new opportunities.

View all posts by Daksh →

Leave a Reply

Your email address will not be published.